LYZ and breast carcinoma: Our results show significantly higher levels of P in MDA-MB 231 compared to nontumoral MCF-10A cells (Fig. 2D) and high levels of LYZ expression with the presence of high-molecular-weight forms of LYZ in breast cancer cells, not detected in stem cells (Fig. 6).